期刊文献+

MMP-2基因多态性与动脉粥样硬化性脑梗死初发及复发相关性研究 被引量:12

Correlations among the matrix metalloproteinase-2 polymorphism and the atherosclerotic cerebral infarction for the first time onset and recurrence
下载PDF
导出
摘要 目的研究基质金属蛋白酶2(MMP-2)基因启动子区1306C/T和735C/T多态性与动脉粥样硬化性脑梗死初发及复发的相关性。方法选取初发脑梗死350例,复发脑梗死340例,正常健康组360例。采用ELISA法检测MMP-2的含量,聚合酶链反应-限制性片段长度多态性(PCR-RFLP)检测MMP-2基因1306C/T和735C/T的基因型,比较3组间MMP-2基因多态性频率分布及含量的差异。结果初发脑梗死组及复发脑梗死组血清MMP-2水平显著高于对照组[(2.93±0.53)vs(1.68±0.24)mg/L,P〈0.01;(3.32±0.94)vs(1.68±0.24)mg/L,P〈0.01],且复发脑梗死组高于初发脑梗死组[(3.32±0.94)vs(2.93±0.53)mg/L,P〈0.01]。MMP-2 735C/T中复发脑梗死组C等位基因频率明显升高,与初发脑梗死组相比(92.5%vs 87.9%,χ2=4.398,P〉0.01)差异无统计学意义,但与对照组相比(92.5%vs 78.5%,χ2=8.121;P〈0.01)差异有统计学意义;初发脑梗死组与对照组相比(87.9%vs 78.5%,χ2=4.121;P〉0.01)差异无统计学意义。3组MMP-2 1306C/T基因型(χ2=1.075,P〉0.01)和等位基因(χ2=1.124,P〉0.01)的频率分布无统计学意义。多变量Logistic回归分析显示,MMP-2 735C/T多态性是脑梗死复发的独立危险因素(OR:1.765,95%CI:1.177~2.676,P=0.006)。结论MMP-2基因735C/T的C等位基因是脑梗死遗传易感基因之一,可能是脑梗死复发的潜在危险因素。 Objective To investigate the correlations between matrix metalloproteinase-2( MMP-2) polymorphism( 1306C/T and 735C/T) and the atherosclerotic cerebral infarction for the first time and recurrence. Methods The study consisted of 350 patients with atherosclerotic cerebral infarction for the first time onset,340 patients with a recurrence of atherosclerotic cerebral infarction,360 healthy subjects as control group. The serum level of MMP-2 was measured by enzyme-linked immunosorbent assay,and the MMP-2 1306 C / T and 735 C / T polymorphism were detected by PCR-restriction fragment length polymorphism. The difference results among the groups were analyzed. Results The serum MMP-2 level in cerebral infarction groups was significantly higher than that in the control group[( 2. 93 ± 0. 53) vs( 1. 68 ± 0. 24) mg / L,P 0. 01;( 3. 32 ± 0. 94) vs( 1. 68 ± 0. 24) mg / L,P 0. 01]. The serum MMP-2 level in the cerebral infarction recurrence group was significantly higher than those in the group of cerebral infarction for the first time onset[( 3. 32 ± 0. 94) vs( 2. 93± 0. 53) mg / L,P 0. 01]. The frequency of C allele of MMP-2 735 C / T in the cerebral infarction recurrence group was significantly higher than the control group( 92. 5% vs 78. 5%,χ2= 8. 121; P 0. 01),and there was no significantly difference in the cerebral infarction for the first time onset( 92. 5% vs 87. 9%,χ2= 4. 398,P 0. 01). There was also no significantly difference between the cerebral infarction for the first time onset and control group( 87. 9% vs 78. 5%,χ2= 4. 121;P 0. 01). There were no significantly difference in the frequencies of genotype( χ2= 1. 075,P 0. 01) and allele( χ2=1. 124,P 0. 01) of MMP-2 1306 C / T among the three groups. Multivariate Logistic regression analysis showed that MMP-2735 C / T polymorphism was an independent risk factor for infarction recurrence( OR 1. 765,95% CI 1. 177 ~ 2. 676,P =0. 006). Conclusions The C allele of MMP-2 735 C / T might be a genetic marker and an independent risk factor for atherosclerotic cerebral infarction recurrence.
出处 《中风与神经疾病杂志》 CAS 北大核心 2015年第2期104-107,共4页 Journal of Apoplexy and Nervous Diseases
基金 四川省遂宁市科知局项目(No.2014015)
关键词 MMP-2 基因多态性 脑梗死 复发 MMP-2 Polymorphism Cerebral infarction Recurrence
  • 相关文献

参考文献13

  • 1中国急性缺血性脑卒中诊治指南2010[J].中华神经科杂志,2010,43(2):146-153. 被引量:3406
  • 2Daskalopoulou SS,Daskalopoulos ME,Perrea D,et al.Carotid artery atherosclerosis:what is the evidence for drug action[J].Curr Pharm Des,2007,13(11):1141-1159.
  • 3Mukherjee D,Patil CG.Epidemiology and the global burden of stroke[J].World Neurosurg,2011,76(6 Suppl):85-90.
  • 4Stylianou IM,Bauer RC,Reilly MP,et al.Genetic basis of atherosclerosis:insights from mice and humans[J].Circ Res,2012,110(2):337-355.
  • 5Wagsater D,Zhu C,Bjorkegren J,et al.MMP-2 and MMP-9 are prominent matrix metalloproteinases during atherosclerosis development in the Ldlr(-/-)Apob(100/100)mouse[J].Int J Mol Med,2011,28(2):247-253.
  • 6中华医学会神经科学会.各类脑血管病诊断要点[J].中华神经科杂志,1996,29:379.
  • 7Han SW,Kim SH,Lee JY,et al.A new subtype classification of ischemic stroke based on treatment and etiologic mechanism[J].Eur Neurol,2007,57(2):96-102.
  • 8Jacob-Ferreira AL,Schulz R.Activation of intracellular matrix metalloproteinase-2 by reactive oxygen-nitrogen species:Consequences and therapeutic strategies in the heart[J].Arch Biochem Biophys,2013,540(1):82-93.
  • 9熊光润,王庆海,王桂祥,赵凌云,林文源,胡大军,胡文法,张清,陈士金.基质金属蛋白酶-2及其抑制剂与颈动脉粥样硬化斑块易损性的关系[J].中华神经医学杂志,2009,8(7):690-693. 被引量:13
  • 10Brouns R,Wauters A,De Surqeloose D,et al.Biochemical markers for blood-brain barrier dysfunction in acute ischemic stroke correlate with evolution and out-come[J].Eur Neurol,2011,65(1):23-31.

二级参考文献32

共引文献3419

同被引文献94

  • 1张晋霞,张志勇,刘斌,李世英,史富华,张蕊.基质金属蛋白酶-1基因多态性与老年脑梗死患者颈动脉粥样硬化程度的相关性[J].中国老年学杂志,2014,34(9):2381-2383. 被引量:1
  • 2张锋,任景怡,陈红.基质金属蛋白酶8在动脉粥样硬化中的研究进展[J].中国动脉硬化杂志,2015,23(6):629-633. 被引量:7
  • 3脑卒中患者临床神经功能缺损程度评分标准(1995)[J].中华神经科杂志,1996,29(6):381-383. 被引量:15752
  • 4Yan HC,Wang W, Dou CW,et d.Relationships of LDLR genetic polymorphisms with cerebral infarction:a meta- analysis[J].Mol Biol Rep, 2014,41 (7) : 4425-4434.
  • 5国家中医药管理局.中药新药临床研究指导原则·第一辑[M].北京:中国医药科技出版社,2002:37-40.
  • 6郑涛.杨淑焕.补阳还五汤加减治疗中风病恢复期4l例[J].辽宁中医杂志,2014,41(7):1438,1439.
  • 7赵光恒,张芳,刘仁斌.补阳还五汤对急性缺血性脑卒中C反应蛋白及血液流变学影响[J].陕西中医,2015,36(5):546-547.
  • 8Mao L, Jian C, Changzhi L, et al. Cytochrome CYP2 C 19 polymorphism and risk of adverse clinical events in clopidogre]-treated patients : a me- ta-analysis based on 23035 subjects [ J ]. Arch Cardiovasc Dis, 2013, 106(10) :517-527.
  • 9Jacob-Ferreira AL, Schulz R. Activation of intracellular matrix metallo- proteinase-2 by reactive oxygen-nitrogen species: Consequences and- therapeutic strategies in the heart [ J ]. Arch Biochem Biophys, 2013, 540( 1 ) :82-93.
  • 10Halder AK,Saha A,Jha T. Exploring QSAR and pharmacophore map- ping of structurally diverse selective matrix metalloproteinase-2 inhibi- tors[J]. J Pharmacol,2013,65(10) :1541-1554.

引证文献12

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部